intravenous coadministration of l-dopa + carbidopa resulted in significant ( p less than 0.05 ) carbidopa-dependent increases in both the area under the plasma l-dopa concentration versus time profile ( auc ; +27 % ) and the plasma l-dopa half-life ( t1/2 ; +35 % ) .
C0353697
l-dopa
C0023570
l-dopa